Cytochrome c: Potential as a noninvasive biomarker of drug-induced acute kidney injury

Expert Opinion on Drug Metabolism and Toxicology

Volumn 8, Issue 6, 2012, Pages 655-664

  Small, David M ^a   Gobe, Glenda C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute kidney injury; Acute renal failure; Apoptosis; Biomarker; Cytochrome c; Mitochondria; Necrosis; Nephrotoxicity

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; ARISTOLOCHIC ACID; CIMETIDINE; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN; CYTOCHROME C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; FOSCARNET; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IFOSFAMIDE; INDOMETACIN; KETOROLAC; MESALAZINE; METHOTREXATE; MITOMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; TACROLIMUS; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; ZOLEDRONIC ACID;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; APOPTOSIS; CELL DAMAGE; CELL DEATH; COMORBIDITY; CREATININE BLOOD LEVEL; CYTOLYSIS; CYTOTOXICITY; DRUG INDUCED ACUTE KIDNEY FAILURE; DRUG INDUCED DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; REVIEW; RHABDOMYOLYSIS; SEPSIS; URINE VOLUME;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CYTOCHROMES C; EARLY DIAGNOSIS; HUMANS; KIDNEY; MITOCHONDRIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS;

EID: 84862104831     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2012.679657     Document Type: Review

References (62)

1. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 2005;351(1-2):31-47 (Pubitemid 39563555)
2. Gobe GC, Endre ZH. Cell death in toxic nephropathies. Semin Nephrol 2003;23(5):416-24 (Pubitemid 37176686)
3. Gobe G. Identification of apoptosis in kidney tissue sections. Methods Mol Biol 2009;466:175-92
4. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11):3365-70 (Pubitemid 46179340)
5. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-18 (Pubitemid 41175724)
6. Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician 2008;78(6):743-50
7. Dieterle F, Sistare F, Goodsaid F, et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium. Nat Biotechnol 2010;28(5):455-62
8. Endre ZH. Acute kidney injury: definitions and new paradigms. Adv Chronic Kidney Dis 2008;15(3):213-21 (Pubitemid 351822594)
9. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006;2(7):364-77 (Pubitemid 44034187)
10. Lameire N, Van Biesen W, Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J AmSoc Nephrol 2006;17(4):923-5
11. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011;7(4):209-17
12. Schumer M, Colombel MC, Sawczuk IS, et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992;140(4):831-8
13. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006;17(6):1503-20 (Pubitemid 43841396)
14. Gobe GC, Axelsen RA. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 1987;56(3):273-81 (Pubitemid 17065347)
15. Hutchison CA, Batuman V, Behrens J, et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 2011;8(1):43-51
16. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15(6):725-31 (Pubitemid 37492933)
17. Gobe GC, Johnson DW. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 2007;39(9):1551-61 (Pubitemid 47088318)
18. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23(5):460-4 (Pubitemid 37176691)
19. Gobe G, Zhang XJ, Willgoss DA, et al. Relationship between expression of Bcl-2 genes and growth factors inischemic acute renal failure in the rat. J Am Soc Nephrol 2000;11(3):454-67 (Pubitemid 30115075)
20. Hall AM, Unwin RJ, Parker N, et al. Multiphoton imaging reveals differences in mitochondrial function between nephron segments. J Am Soc Nephrol 2009;20(6):1293-302
21. Racusen LC, Fivush BA, Li YL, et al. Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis". Lab Invest 1991;64(4):546-56
22. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3(2):481-90
23. Zhou H, Hewitt SM. Yuen PS, et al. acute kidney injury biomarkers - needs, present status, and future promise. Nephrol Self Assess Program 2006;5(2):63-71
24. Sirota JC, Klawitter J, Edelstein CL. Biomarkers of acute kidney injury. J Toxicol 2011;2011:328120
25. Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992;38(Suppl 1):S14-19 (Pubitemid 23092540)
26. Westhuyzen J, Endre ZH, Reece G, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003;18(3):543-51 (Pubitemid 36305660)
27. Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62(1):237-44 (Pubitemid 34754067)
28. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365(9466):1231-8 (Pubitemid 40469655)
29. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16(10):3046-52 (Pubitemid 44743502)
30. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70(1):199-203 (Pubitemid 44000139)
31. Mehta RL. Urine IL-18 levels as a predictor of acute kidney injury in intensive care patients. Nat Clin Pract Nephrol 2006;2(5):252-3 (Pubitemid 43787257)
32. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008; 73(9):1008-16 (Pubitemid 351543898)
33. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148(11):810-19 (Pubitemid 351786928)
34. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40(2):221-6 (Pubitemid 34827638)
35. Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61(4):1453-61 (Pubitemid 34304506)
36. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/ reperfusion. Kidney Int 2003;63(5):1714-24 (Pubitemid 36513317)
37. Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24(3):307-15 (Pubitemid 39070114)
38. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115(3):610-21 (Pubitemid 40322235)
39. Ichimura T, Hung CC, Yang SA, et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286(3):F552-63 (Pubitemid 38233650)
40. Vella JP, Harris S, Garrison K, et al. Transcripts for kidney injury molecule-1 (Kim-1) are a specific biomarker predicting delayed graft function in kidney transplantation. Transplantation 2006;82(1):201
41. O'Toole JF, Patel HV, Naples CJ, et al. Decreased cytochrome c mediates an age-related decline of oxidative phosphorylation in rat kidney mitochondria. Biochem J 2010;427(1):105-12
42. Iverson SL, Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 2004;423(1):37-46 (Pubitemid 38198211)
43. Tuominen EK, Wallace CJ, Kinnunen PK. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J Biol Chem 2002;277(11):8822-6 (Pubitemid 34952948)
44. Kluck RM, Bossy-Wetzel E, Green DR, et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275(5303):1132-6 (Pubitemid 27097313)
45. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94(4):481-90 (Pubitemid 28391864)
46. Cuttle L, Zhang XJ, Endre ZH, et al. Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int 2001;59(5):1779-88 (Pubitemid 32336792)
47. Li YZ, Li CJ, Pinto AV, et al. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med 1999;5(4):232-9 (Pubitemid 29279751)
48. Goldstein JC, Waterhouse NJ, Juin P, et al. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2000;2(3):156-62
49. Beachy SH, Repasky EA. Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update. Cancer Immunol Immunother 2008;57(6):759-75
50. Barczyk K, Kreuter M, Pryjma J, et al. Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 2005;116(2):167-73 (Pubitemid 40967251)
51. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007;30(4):277-94 (Pubitemid 46624528)
52. Miller TJ, Knapton A, Adeyemo O, et al. Cytochrome c: a non-invasive biomarker of drug-induced liver injury. J Appl Toxicol 2008;28(7):815-28
53. Nakama T, Hirono S, Moriuchi A, et al. Etoposide prevents apoptosis in mouse liver with D-galactosamine/ lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology 2001;33(6):1441-50 (Pubitemid 32496981)
54. Knight TR, Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002;181(2):133-41 (Pubitemid 34625944)
55. Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int 2004; 24(2):85-9 (Pubitemid 38584992)
56. Tao Y, Kim J, Stanley M, et al. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD). Kidney Int 2005;67(3):909-19 (Pubitemid 41623315)
57. Brooks C, Wei Q, Cho SG, et al. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009;119(5):1275-85
58. Zager RA, Johnson AC, Hanson SY. Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury. Kidney Int 2004;65(6):2123-34 (Pubitemid 38669998)
59. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stressand plasma membrane integrity. Kidney Int 2003;64(1):128-39 (Pubitemid 36714165)
60. Renz A, Berdel WE, Kreuter M, et al. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001; 98(5):1542-8
61. Lund U, Rippe A, Venturoli D, et al. Glomerular filtration rate dependence of sieving of albumin and someneutral proteins in rat kidneys. Am J Physiol Renal Physiol2003;284(6):F1226-3
62. Kunitomo R, Miyauchi Y, Inoue M. Synthesis of a cytochrome c derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat. J Biol Chem 1992;267(13):8732-8